GlobeStar Therapeutics Corp (GSTC) Financial Statements

GlobeStar Therapeutics Corp (GSTC) files with the U.S. Securities and Exchange Commission under CIK 0001502152. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2023

Net Income: -$1.95 million
Net Cash from Operations: -$205.76 thousand

Fiscal year ended Sep 30, 2023. Latest periodic SEC filing: Oct 11, 2024. Source: SEC filings (EDGAR XBRL).

Open the full financial statements for GSTC in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History